Tarveda Therapeutics, Inc. — Form D

Tarveda Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-28. The offering totals $15.4M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
James BarrettDirectorRichmond, VA
Dennis AusielloDirectorSan Jose, CA
Andrew FromkinDirectorNew York, NY
Andrew FromkinExecutive OfficerNew York, NY
Aymeric SallinDirectorSanta Clara, CA
Aymeric S SallinDirectorGaithersburg, MD
Peter Barton HuttDirectorSalt Lake City, UT
Brian RobertsDirectorNew York, NY
Brian RobertsExecutive OfficerNew York, NY
Michael MetzgerDirectorWatertown, MA
Nilesh KumarDirectorWatertown, MA
Guido MagniDirectorWatertown, MA
Robert J LangerDirectorWoburn, MA
Aymeric J SallinDirectorWatertown, MA
Nilesh J KumarDirectorWatertown, MA
Guido J MagniDirectorWatertown, MA
Omid J FarokhzadDirectorWatertown, MA
Andrew J FromkinDirectorWatertown, MA
Andrew J FromkinExecutive OfficerWatertown, MA
Robert S LangerDirectorNewton, MA
Robert S LangerPromoterNewton, MA
Dennis J AusielloDirectorCambridge, MA
Omid FarokhzadDirectorBoston, MA
Omid C FarokhzadDirectorWatertown, MA
Omid C FarokhzadPromoterWatertown, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2021-09-27D$6.0M$6.0M
2019-12-26D$13.6M$13.6M
2017-02-09D$30.0M$30.0M
2017-02-09D/A$38.0M$38.0M
2016-01-29D$38.0M$25.5M
2014-03-12D$1000K$1000K
2013-12-24D/A$21.0M$21.0M
2012-12-20D$21.0M$16.0M
2011-09-02D$2.8M$2.8M

More